OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The association between IgG and IgM antibodies against cardiolipin, β2-glycoprotein I and Domain I of β2-glycoprotein I with disease profile in patients with multiple sclerosis
Natalia Filippidou, George Krashias, Charis Pericleous, et al.
Molecular Immunology (2016) Vol. 75, pp. 161-167
Open Access | Times Cited: 17
Natalia Filippidou, George Krashias, Charis Pericleous, et al.
Molecular Immunology (2016) Vol. 75, pp. 161-167
Open Access | Times Cited: 17
Showing 17 citing articles:
Prevalence and Thrombotic Risk Assessment of Anti-β2 Glycoprotein I Domain I Antibodies: A Systematic Review
Massimo Radin, Irene Cecchi, Dario Roccatello, et al.
Seminars in Thrombosis and Hemostasis (2017) Vol. 44, Iss. 05, pp. 466-474
Closed Access | Times Cited: 63
Massimo Radin, Irene Cecchi, Dario Roccatello, et al.
Seminars in Thrombosis and Hemostasis (2017) Vol. 44, Iss. 05, pp. 466-474
Closed Access | Times Cited: 63
Neurologic Manifestations of the Antiphospholipid Syndrome — an Update
Miguel Leal Rato, Matilde Bandeira, Vasco C. Romão, et al.
Current Neurology and Neuroscience Reports (2021) Vol. 21, Iss. 8
Open Access | Times Cited: 46
Miguel Leal Rato, Matilde Bandeira, Vasco C. Romão, et al.
Current Neurology and Neuroscience Reports (2021) Vol. 21, Iss. 8
Open Access | Times Cited: 46
ESCLEROSIS MÚLTIPLE Y ENFERMEDADES REUMATOLÓGICAS: ARTRITIS REUMATOIDE, SÍNDROME ANTIFOSFOLÍPIDO Y LUPUS ERITEMATOSO SISTÉMICO
Mónica Hernández, Bernardo González, Y. Contreras, et al.
Neurology Perspectives (2025), pp. 100197-100197
Open Access
Mónica Hernández, Bernardo González, Y. Contreras, et al.
Neurology Perspectives (2025), pp. 100197-100197
Open Access
Antiphospholipid Antibodies Overlapping in Isolated Neurological Syndrome and Multiple Sclerosis: Neurobiological Insights and Diagnostic Challenges
Chiara D’Angelo, Oriol Franch, Lidia Fernández-Paredes, et al.
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 25
Chiara D’Angelo, Oriol Franch, Lidia Fernández-Paredes, et al.
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 25
A Comparison of Two Analytical Approaches for the Quantification of Neurofilament Light Chain, a Biomarker of Axonal Damage in Multiple Sclerosis
Anna Pafiti, George Krashias, John S. Tzartos, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10787-10787
Open Access | Times Cited: 7
Anna Pafiti, George Krashias, John S. Tzartos, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10787-10787
Open Access | Times Cited: 7
Relevance of antiphospholipid antibodies in multiple sclerosis: A systematic review and meta analysis
Mira Merashli, José Delgado Alves, Fabrizio Gentile, et al.
Seminars in Arthritis and Rheumatism (2016) Vol. 46, Iss. 6, pp. 810-818
Closed Access | Times Cited: 17
Mira Merashli, José Delgado Alves, Fabrizio Gentile, et al.
Seminars in Arthritis and Rheumatism (2016) Vol. 46, Iss. 6, pp. 810-818
Closed Access | Times Cited: 17
A systems medicine approach reveals disordered immune system and lipid metabolism in multiple sclerosis patients
Mehrdad Pazhouhandeh, Mohammad Ali Sahraian, Seyed Davar Siadat, et al.
Clinical & Experimental Immunology (2017) Vol. 192, Iss. 1, pp. 18-32
Open Access | Times Cited: 17
Mehrdad Pazhouhandeh, Mohammad Ali Sahraian, Seyed Davar Siadat, et al.
Clinical & Experimental Immunology (2017) Vol. 192, Iss. 1, pp. 18-32
Open Access | Times Cited: 17
Prevalence of Antiphospholipid Antibodies Negativisation in Patients with Antiphospholipid Syndrome: A Long-Term Follow-Up Multicentre Study
Massimo Radin, Karen Schreiber, Savino Sciascia, et al.
Thrombosis and Haemostasis (2019) Vol. 119, Iss. 12, pp. 1920-1926
Closed Access | Times Cited: 16
Massimo Radin, Karen Schreiber, Savino Sciascia, et al.
Thrombosis and Haemostasis (2019) Vol. 119, Iss. 12, pp. 1920-1926
Closed Access | Times Cited: 16
The Significance of Antibodies against Domain I of Beta-2 Glycoprotein I in Antiphospholipid Syndrome
Walid Chayouâ, Hilde Kelchtermans, Bas de Laat
Seminars in Thrombosis and Hemostasis (2017) Vol. 44, Iss. 05, pp. 458-465
Closed Access | Times Cited: 14
Walid Chayouâ, Hilde Kelchtermans, Bas de Laat
Seminars in Thrombosis and Hemostasis (2017) Vol. 44, Iss. 05, pp. 458-465
Closed Access | Times Cited: 14
A Preclinical Investigation on the Role of IgG Antibodies against Coagulant Components in Multiple Sclerosis
Maria S. Hadjiagapiou, George Krashias, Elie Deeba, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 906-906
Open Access | Times Cited: 4
Maria S. Hadjiagapiou, George Krashias, Elie Deeba, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 906-906
Open Access | Times Cited: 4
Autoantibodies of IgM and IgG classes show differences in recognition of multiple autoantigens in chronic obstructive pulmonary disease
Reham Shindi, Amna Almehairi, Ola H. Negm, et al.
Clinical Immunology (2017) Vol. 183, pp. 344-353
Open Access | Times Cited: 10
Reham Shindi, Amna Almehairi, Ola H. Negm, et al.
Clinical Immunology (2017) Vol. 183, pp. 344-353
Open Access | Times Cited: 10
Stroke risk in multiple sclerosis: a critical appraisal of the literature
Triantafyllos Doskas, Efthimios Dardiotis, George D. Vavougios, et al.
International Journal of Neuroscience (2022) Vol. 133, Iss. 10, pp. 1132-1152
Closed Access | Times Cited: 4
Triantafyllos Doskas, Efthimios Dardiotis, George D. Vavougios, et al.
International Journal of Neuroscience (2022) Vol. 133, Iss. 10, pp. 1132-1152
Closed Access | Times Cited: 4
Autoantibody profile in sarcoidosis, analysis from the GRADS sarcoidosis cohort
Basheer Khassawneh, Chengsong Zhu, Briana Barkes, et al.
PLoS ONE (2022) Vol. 17, Iss. 10, pp. e0274381-e0274381
Open Access | Times Cited: 4
Basheer Khassawneh, Chengsong Zhu, Briana Barkes, et al.
PLoS ONE (2022) Vol. 17, Iss. 10, pp. e0274381-e0274381
Open Access | Times Cited: 4
The possible role of an autoimmune mechanism in the etiopathogenesis of Parkinson’s disease
Savvas Dalitis, Natalia Filippidou, George Krashias, et al.
Journal of Clinical Neuroscience (2018) Vol. 54, pp. 63-68
Closed Access | Times Cited: 5
Savvas Dalitis, Natalia Filippidou, George Krashias, et al.
Journal of Clinical Neuroscience (2018) Vol. 54, pp. 63-68
Closed Access | Times Cited: 5
Mechanisms of activation induced by antiphospholipid antibodies in multiple sclerosis: Potential biomarkers of disease?
Natalia Filippidou, George Krashias, Christina Christodoulou, et al.
Journal of Immunological Methods (2019) Vol. 474, pp. 112663-112663
Open Access | Times Cited: 4
Natalia Filippidou, George Krashias, Christina Christodoulou, et al.
Journal of Immunological Methods (2019) Vol. 474, pp. 112663-112663
Open Access | Times Cited: 4
Neurovascular Issues in Antiphospholipid Syndrome: Arterial Vasculopathy from Small to Large Vessels in a Neuroradiological Perspective
Marialuisa Zedde, Ilaria Grisendi, Federica Assenza, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 13, pp. 3667-3667
Open Access
Marialuisa Zedde, Ilaria Grisendi, Federica Assenza, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 13, pp. 3667-3667
Open Access
Markers of Autoimmune Rheumatic Diseases
Simone Baldovino, Irene Cecchi, Massimo Radin, et al.
Rare diseases of the immune system (2024), pp. 387-426
Closed Access
Simone Baldovino, Irene Cecchi, Massimo Radin, et al.
Rare diseases of the immune system (2024), pp. 387-426
Closed Access
